Antihelminthics Market Key Findings by 2031
The Antihelminthics Market is expected to register a CAGR of 4% from 2023 to 2031, with a market size expanding from US$ XX million in 2023 to US$ XX Million by 2031.
The Antihelminthics Market Report is segmented by type into Benzimidazoles, Abamectin, Salicylanilides, and Praziquantel. The application segment includes Schistosomiasis, Fasciolasis, Filariasis, Angiostrongylosis, Ascariasis, and Giardiasis. The end-user segment includes Hospitals. The market evaluation is presented in US$ for the above segmental analysis. The global analysis is broken down at the regional level and major countries. The market evaluation is presented in US$ for the above segmental analysis.
Purpose of the ReportThe report Antihelminthics Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Antihelminthics Market Segmentation
Type- Benzimidazoles
- Abamectin
- Salicylanilides
- Praziquantel
- Schistosomiasis
- Fasciolasis
- Filariasis
- Angiostrongylosis
- Ascariasis
- Giardiasis
- Hospital
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Antihelminthics Market Growth Drivers- Increase in Helminth Infections: The rising incidence of helminth infections, particularly in countries with poor sanitation and hygiene, is a key driver of the antihelminthics market growth.
- Healthcare Investment and Expenditure: Increased investment in healthcare infrastructure and growing healthcare spending in developing countries contribute to the expansion of the market.
- Awareness of Preventive Measures: The growing awareness of preventive measures and early diagnosis of helminth infections is driving demand for antihelminthic treatments.
- Availability of Generic Drugs: The availability of generic and affordable antihelminthic drugs to a wider population is a significant factor influencing the market's growth.
- Innovative Drug Delivery Systems: Emerging drug delivery systems, such as oral disintegrating tablets and sustained-release formulations, are improving patient compliance and the efficiency of treatment in the antihelminthics market.
- Preventive Programs and Mass Drug Administrations: The growing demand for preventive programs, including mass drug administrations, is contributing to increased demand for antihelminthic treatments.
- Advances in Diagnostics and Early Intervention: Recent advances in point-of-care tests and diagnostic technology are enabling prompt diagnosis and early intervention, enhancing treatment and prevention efforts.
- Resistance and Development of New Drugs: The rise in drug resistance is driving the need for novel antihelminthic drugs, with pharmaceutical companies focusing on developing more effective treatments.
- Research on New Anthelminthic Drugs: The development of new anthelminthic drugs with higher efficacy and improved safety profiles, especially for drug-resistant strains, presents a significant market opportunity.
- Focus on Neglected Tropical Diseases: Growing attention to neglected tropical diseases, including those caused by helminth infections, broadens the scope of the antihelminthics market.
- Affordability and Accessibility of Diagnostics: Improved affordability and accessibility of diagnostic tools will promote early detection and increase demand for treatments.
- Collaboration for Drug Diffusion: Collaboration between pharmaceutical companies, government institutions, and non-profit organizations can enhance the development and distribution of effective antihelminthic drugs in underserved regions.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Antihelminthics Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Antihelminthics Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Antihelminthics Market is expected to grow at a CAGR of 4% between 2023-2031
Several factors are driving the antihelminthics market. A major driver is the rising prevalence of helminth infections, especially in regions with poor sanitation and hygiene. Rising healthcare expenditure and investments in healthcare infrastructure, particularly in developing countries, are also propelling the market. In addition, growing awareness about preventive measures and early diagnosis of helminth infections is boosting demand. Increasing treatment reach to a larger population because of the availability of inexpensive and generic antihelminthic drugs further boosts the market.
Preventive measures including mass drug administration programs increase the scope for this market. Advances in diagnostic technologies will provide early detection and prompt treatment of helminth infections. The increasing prevalence of drug resistance among helminths is a significant challenge, and pharmaceutical companies are working on new antihelminthic agents to overcome this issue. Growing population and accelerating urbanization across the globe are expected to increase the demand for effective antihelminthic therapies, thereby driving growth in the market in the future.
The leading players of the market are: Sanofi, ZEISS International, Johnson and Johnson Services, Merck and Co., Inc., Abbott, Bayer AG, Astellas Pharma Inc., ALLERGAN, Novartis AG., GlaxoSmithKline Plc.
The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.
Some of the customization options available based on request are additional 3–5 company profiles and country-specific analysis of 3–5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Antihelminthics Market - By Type
1.3.2 Antihelminthics Market - By Application
1.3.3 Antihelminthics Market - By End User
1.3.4 Antihelminthics Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ANTIHELMINTHICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. ANTIHELMINTHICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ANTIHELMINTHICS MARKET - GLOBAL MARKET ANALYSIS
6.1. ANTIHELMINTHICS - GLOBAL MARKET OVERVIEW
6.2. ANTIHELMINTHICS - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. ANTIHELMINTHICS MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. BENZIMIDAZOLES
7.3.1. Overview
7.3.2. Benzimidazoles Market Forecast and Analysis
7.4. ABAMECTIN
7.4.1. Overview
7.4.2. Abamectin Market Forecast and Analysis
7.5. SALICYLANILIDES
7.5.1. Overview
7.5.2. Salicylanilides Market Forecast and Analysis
7.6. PRAZIQUANTEL
7.6.1. Overview
7.6.2. Praziquantel Market Forecast and Analysis
8. ANTIHELMINTHICS MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. SCHISTOSOMIASIS
8.3.1. Overview
8.3.2. Schistosomiasis Market Forecast and Analysis
8.4. FASCIOLASIS
8.4.1. Overview
8.4.2. Fasciolasis Market Forecast and Analysis
8.5. FILARIASIS
8.5.1. Overview
8.5.2. Filariasis Market Forecast and Analysis
8.6. ANGIOSTRONGYLOSIS
8.6.1. Overview
8.6.2. Angiostrongylosis Market Forecast and Analysis
8.7. ASCARIASIS
8.7.1. Overview
8.7.2. Ascariasis Market Forecast and Analysis
8.8. GIARDIASIS
8.8.1. Overview
8.8.2. Giardiasis Market Forecast and Analysis
9. ANTIHELMINTHICS MARKET - REVENUE AND FORECASTS TO 2028 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL
9.3.1. Overview
9.3.2. Hospital Market Forecast and Analysis
9.4. OTHERS
9.4.1. Overview
9.4.2. Others Market Forecast and Analysis
10. ANTIHELMINTHICS MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Antihelminthics Market Overview
10.1.2 North America Antihelminthics Market Forecasts and Analysis
10.1.3 North America Antihelminthics Market Forecasts and Analysis - By Type
10.1.4 North America Antihelminthics Market Forecasts and Analysis - By Application
10.1.5 North America Antihelminthics Market Forecasts and Analysis - By End User
10.1.6 North America Antihelminthics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Antihelminthics Market
10.1.6.1.1 United States Antihelminthics Market by Type
10.1.6.1.2 United States Antihelminthics Market by Application
10.1.6.1.3 United States Antihelminthics Market by End User
10.1.6.2 Canada Antihelminthics Market
10.1.6.2.1 Canada Antihelminthics Market by Type
10.1.6.2.2 Canada Antihelminthics Market by Application
10.1.6.2.3 Canada Antihelminthics Market by End User
10.1.6.3 Mexico Antihelminthics Market
10.1.6.3.1 Mexico Antihelminthics Market by Type
10.1.6.3.2 Mexico Antihelminthics Market by Application
10.1.6.3.3 Mexico Antihelminthics Market by End User
10.2. EUROPE
10.2.1 Europe Antihelminthics Market Overview
10.2.2 Europe Antihelminthics Market Forecasts and Analysis
10.2.3 Europe Antihelminthics Market Forecasts and Analysis - By Type
10.2.4 Europe Antihelminthics Market Forecasts and Analysis - By Application
10.2.5 Europe Antihelminthics Market Forecasts and Analysis - By End User
10.2.6 Europe Antihelminthics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Antihelminthics Market
10.2.6.1.1 Germany Antihelminthics Market by Type
10.2.6.1.2 Germany Antihelminthics Market by Application
10.2.6.1.3 Germany Antihelminthics Market by End User
10.2.6.2 France Antihelminthics Market
10.2.6.2.1 France Antihelminthics Market by Type
10.2.6.2.2 France Antihelminthics Market by Application
10.2.6.2.3 France Antihelminthics Market by End User
10.2.6.3 Italy Antihelminthics Market
10.2.6.3.1 Italy Antihelminthics Market by Type
10.2.6.3.2 Italy Antihelminthics Market by Application
10.2.6.3.3 Italy Antihelminthics Market by End User
10.2.6.4 Spain Antihelminthics Market
10.2.6.4.1 Spain Antihelminthics Market by Type
10.2.6.4.2 Spain Antihelminthics Market by Application
10.2.6.4.3 Spain Antihelminthics Market by End User
10.2.6.5 United Kingdom Antihelminthics Market
10.2.6.5.1 United Kingdom Antihelminthics Market by Type
10.2.6.5.2 United Kingdom Antihelminthics Market by Application
10.2.6.5.3 United Kingdom Antihelminthics Market by End User
10.2.6.6 Rest of Europe Antihelminthics Market
10.2.6.6.1 Rest of Europe Antihelminthics Market by Type
10.2.6.6.2 Rest of Europe Antihelminthics Market by Application
10.2.6.6.3 Rest of Europe Antihelminthics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Antihelminthics Market Overview
10.3.2 Asia-Pacific Antihelminthics Market Forecasts and Analysis
10.3.3 Asia-Pacific Antihelminthics Market Forecasts and Analysis - By Type
10.3.4 Asia-Pacific Antihelminthics Market Forecasts and Analysis - By Application
10.3.5 Asia-Pacific Antihelminthics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Antihelminthics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Antihelminthics Market
10.3.6.1.1 Australia Antihelminthics Market by Type
10.3.6.1.2 Australia Antihelminthics Market by Application
10.3.6.1.3 Australia Antihelminthics Market by End User
10.3.6.2 China Antihelminthics Market
10.3.6.2.1 China Antihelminthics Market by Type
10.3.6.2.2 China Antihelminthics Market by Application
10.3.6.2.3 China Antihelminthics Market by End User
10.3.6.3 India Antihelminthics Market
10.3.6.3.1 India Antihelminthics Market by Type
10.3.6.3.2 India Antihelminthics Market by Application
10.3.6.3.3 India Antihelminthics Market by End User
10.3.6.4 Japan Antihelminthics Market
10.3.6.4.1 Japan Antihelminthics Market by Type
10.3.6.4.2 Japan Antihelminthics Market by Application
10.3.6.4.3 Japan Antihelminthics Market by End User
10.3.6.5 South Korea Antihelminthics Market
10.3.6.5.1 South Korea Antihelminthics Market by Type
10.3.6.5.2 South Korea Antihelminthics Market by Application
10.3.6.5.3 South Korea Antihelminthics Market by End User
10.3.6.6 Rest of Asia-Pacific Antihelminthics Market
10.3.6.6.1 Rest of Asia-Pacific Antihelminthics Market by Type
10.3.6.6.2 Rest of Asia-Pacific Antihelminthics Market by Application
10.3.6.6.3 Rest of Asia-Pacific Antihelminthics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Antihelminthics Market Overview
10.4.2 Middle East and Africa Antihelminthics Market Forecasts and Analysis
10.4.3 Middle East and Africa Antihelminthics Market Forecasts and Analysis - By Type
10.4.4 Middle East and Africa Antihelminthics Market Forecasts and Analysis - By Application
10.4.5 Middle East and Africa Antihelminthics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Antihelminthics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Antihelminthics Market
10.4.6.1.1 South Africa Antihelminthics Market by Type
10.4.6.1.2 South Africa Antihelminthics Market by Application
10.4.6.1.3 South Africa Antihelminthics Market by End User
10.4.6.2 Saudi Arabia Antihelminthics Market
10.4.6.2.1 Saudi Arabia Antihelminthics Market by Type
10.4.6.2.2 Saudi Arabia Antihelminthics Market by Application
10.4.6.2.3 Saudi Arabia Antihelminthics Market by End User
10.4.6.3 U.A.E Antihelminthics Market
10.4.6.3.1 U.A.E Antihelminthics Market by Type
10.4.6.3.2 U.A.E Antihelminthics Market by Application
10.4.6.3.3 U.A.E Antihelminthics Market by End User
10.4.6.4 Rest of Middle East and Africa Antihelminthics Market
10.4.6.4.1 Rest of Middle East and Africa Antihelminthics Market by Type
10.4.6.4.2 Rest of Middle East and Africa Antihelminthics Market by Application
10.4.6.4.3 Rest of Middle East and Africa Antihelminthics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Antihelminthics Market Overview
10.5.2 South and Central America Antihelminthics Market Forecasts and Analysis
10.5.3 South and Central America Antihelminthics Market Forecasts and Analysis - By Type
10.5.4 South and Central America Antihelminthics Market Forecasts and Analysis - By Application
10.5.5 South and Central America Antihelminthics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Antihelminthics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Antihelminthics Market
10.5.6.1.1 Brazil Antihelminthics Market by Type
10.5.6.1.2 Brazil Antihelminthics Market by Application
10.5.6.1.3 Brazil Antihelminthics Market by End User
10.5.6.2 Argentina Antihelminthics Market
10.5.6.2.1 Argentina Antihelminthics Market by Type
10.5.6.2.2 Argentina Antihelminthics Market by Application
10.5.6.2.3 Argentina Antihelminthics Market by End User
10.5.6.3 Rest of South and Central America Antihelminthics Market
10.5.6.3.1 Rest of South and Central America Antihelminthics Market by Type
10.5.6.3.2 Rest of South and Central America Antihelminthics Market by Application
10.5.6.3.3 Rest of South and Central America Antihelminthics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. ANTIHELMINTHICS MARKET, KEY COMPANY PROFILES
12.1. ABBOTT
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. NOVARTIS AG
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. ZEISS INTERNATIONAL
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. JOHNSON AND JOHNSON SERVICES
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SANOFI
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MERCK AND CO., INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GLAXOSMITHKLINE PLC
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ASTELLAS PHARMA INC,
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. BAYER AG
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ALLERGAN
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Abbott
2. Novartis AG
3. ZEISS International
4. Johnson and Johnson Services
5. Sanofi
6. Merck and Co., Inc.
7. GlaxoSmithKline plc
8. Astellas Pharma Inc,
9. Bayer AG
10. ALLERGAN
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For